{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:19:03Z","timestamp":1792423143664,"version":"4.5.0"},"reference-count":40,"publisher":"SAGE Publications","issue":"1-2","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Substance Abuse"],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Patients receiving buprenorphine for the treatment of opioid use disorder (OUD) experience a roughly 50% reduction in mortality risk relative to those not receiving medication. Longer periods of treatment are also associated with improved clinical outcomes. Despite this, patients often express desires to discontinue treatment and some view taper as treatment success. Little is known about the beliefs and medication perspectives of patients engaged in long-term buprenorphine treatment that may underlie motivations to discontinue.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This study was conducted at the VA Portland Health Care System (2019-2020). Qualitative interviews were conducted with participants prescribed buprenorphine for \u22652\u2009years. Coding and analysis were guided by directed qualitative content analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Fourteen patients engaged in office-based buprenorphine treatment completed interviews. While patients expressed strong enthusiasm for buprenorphine as a medication, the majority expressed the desire to discontinue, including patients actively tapering. Motivations to discontinue fell into 4 categories. First, patients were troubled by perceived side effects of the medication, including effects on sleep, emotion, and memory. Second, patients expressed unhappiness with being \u201cdependent\u201d on buprenorphine, framed in opposition to personal strength\/independence. Third, patients expressed stigmatized beliefs about buprenorphine, describing it as \u201cillicit,\u201d and associated with past drug use. Finally, patients expressed fears about buprenorphine unknowns, including potential long-term health effects and interactions with medications required for surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Despite recognizing benefits, many patients engaged in long-term buprenorphine treatment express a desire to discontinue. Findings from this study may help clinicians anticipate patient concerns and can be used to inform shared decision-making conversations regarding buprenorphine treatment duration.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/08897077231165625","type":"journal-article","created":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T03:07:33Z","timestamp":1683083253000},"page":"41-50","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":7,"title":["\u201cI\u2019m Clean and Sober, But Not Necessarily Free\u201d: Perceptions of Buprenorphine Among Patients in Long-Term Treatment"],"prefix":"10.1177","volume":"44","author":[{"given":"Jessica J.","family":"Wyse","sequence":"first","affiliation":[{"name":"Center to Improve Veteran Involvement in Care, VA Portland Health Care System, Portland, OR, USA"},{"name":"School of Public Health, Oregon Health & Science University-Portland State University, Portland, OR, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis I.","family":"Lovejoy","sequence":"additional","affiliation":[{"name":"Center to Improve Veteran Involvement in Care, VA Portland Health Care System, Portland, OR, USA"},{"name":"School of Public Health, Oregon Health & Science University-Portland State University, Portland, OR, USA"},{"name":"Department of Psychiatry, Oregon Health & Science University, Portland, OR, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam J.","family":"Gordon","sequence":"additional","affiliation":[{"name":"Informatics, Decision-Enhancement, and Analytic Sciences (IDEAS) Center, VA Salt Lake City Health Care System, Salt Lake City, UT, USA"},{"name":"Division of Epidemiology & Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Mackey","sequence":"additional","affiliation":[{"name":"Center to Improve Veteran Involvement in Care, VA Portland Health Care System, Portland, OR, USA"},{"name":"Department of General Internal Medicine & Geriatrics, Oregon Health & Science University, Portland, OR, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Herreid-O\u2019Neill","sequence":"additional","affiliation":[{"name":"Oregon Rural Practice Network (ORPRN), Oregon Health & Science University, Portland, OR, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin J.","family":"Morasco","sequence":"additional","affiliation":[{"name":"Center to Improve Veteran Involvement in Care, VA Portland Health Care System, Portland, OR, USA"},{"name":"Department of Psychiatry, Oregon Health & Science University, Portland, OR, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2023,5,3]]},"reference":[{"issue":"2","key":"bibr1-08897077231165625","volume":"6","author":"Mattick RP","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"bibr2-08897077231165625","unstructured":"Department of Veterans Affairs, Department of Defense. VA\/DOD Clinical Practice Guideline: Management of Substance Use Disorder (SUD) 2021. Accessed May 24, 2022. https:\/\/www.healthquality.va.gov\/guidelines\/MH\/sud\/"},{"key":"bibr3-08897077231165625","doi-asserted-by":"publisher","DOI":"10.7326\/M17-3107"},{"key":"bibr4-08897077231165625","volume-title":"Medications for Opioid Use Disorder Save Lives","author":"National Academies of Sciences E and Medicine","year":"2019"},{"key":"bibr5-08897077231165625","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2019.01085"},{"key":"bibr6-08897077231165625","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.20622"},{"key":"bibr7-08897077231165625","doi-asserted-by":"publisher","DOI":"10.1111\/add.15959"},{"key":"bibr8-08897077231165625","doi-asserted-by":"publisher","DOI":"10.1111\/add.13270"},{"key":"bibr9-08897077231165625","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2019.19060612"},{"key":"bibr10-08897077231165625","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000789"},{"key":"bibr11-08897077231165625","doi-asserted-by":"publisher","DOI":"10.1111\/ajad.12884"},{"key":"bibr12-08897077231165625","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2010.08.001"},{"key":"bibr13-08897077231165625","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2022.108804"},{"key":"bibr14-08897077231165625","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2022.2095082"},{"key":"bibr15-08897077231165625","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108646"},{"key":"bibr16-08897077231165625","volume-title":"Improving the Quality of Health Care for Mental and Substance-Use Conditions","author":"Institute of Medicine (US)","year":"2006"},{"key":"bibr17-08897077231165625","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1109283"},{"key":"bibr18-08897077231165625","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c5146"},{"key":"bibr19-08897077231165625","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2019.01.019"},{"key":"bibr20-08897077231165625","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2020.108125"},{"key":"bibr21-08897077231165625","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2019.1671940"},{"key":"bibr22-08897077231165625","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2020.02.013"},{"key":"bibr23-08897077231165625","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2020.108146"},{"key":"bibr24-08897077231165625","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2015.12.031"},{"key":"bibr25-08897077231165625","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2013.02.008"},{"key":"bibr26-08897077231165625","doi-asserted-by":"publisher","DOI":"10.1080\/10826084.2017.1385633"},{"key":"bibr27-08897077231165625","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2014.941085"},{"key":"bibr28-08897077231165625","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2015.04.002"},{"key":"bibr29-08897077231165625","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2015.1088496"},{"key":"bibr30-08897077231165625","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2018.02.018"},{"key":"bibr31-08897077231165625","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2014.921743"},{"key":"bibr32-08897077231165625","doi-asserted-by":"publisher","DOI":"10.1177\/11782218221103859"},{"key":"bibr33-08897077231165625","doi-asserted-by":"publisher","DOI":"10.1186\/s13722-022-00312-7"},{"key":"bibr34-08897077231165625","doi-asserted-by":"publisher","DOI":"10.1177\/1049732305276687"},{"key":"bibr35-08897077231165625","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-020-06115-3"},{"key":"bibr36-08897077231165625","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-021-07118-4"},{"key":"bibr37-08897077231165625","unstructured":"National Council on Behavioral Health. Challenging the Myths About Medication Assisted Treatment (MAT) for Opioid Use Disorder (OUD). Accessed July 12, 2022. https:\/\/www.opioidlibrary.org\/wp-content\/uploads\/2019\/06\/NCBH_MAT_MythsVFacts.pdf"},{"key":"bibr38-08897077231165625","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108923"},{"key":"bibr39-08897077231165625","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.37238"},{"key":"bibr40-08897077231165625","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2020.1787299"}],"updated-by":[{"DOI":"10.1177\/08897077231185670","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T00:00:00Z","timestamp":1689638400000}}],"container-title":["Substance Abuse"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/08897077231165625","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/08897077231165625","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/08897077231165625","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T20:40:11Z","timestamp":1777668011000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/08897077231165625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":40,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["10.1177\/08897077231165625"],"URL":"https:\/\/doi.org\/10.1177\/08897077231165625","relation":{},"ISSN":["0889-7077","1547-0164"],"issn-type":[{"value":"0889-7077","type":"print"},{"value":"1547-0164","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1]]}}}